Advertisement

Topics

FDA targets regulatory 'gaming' in effort to boost generic competition

08:12 EDT 21 Jun 2017 | BioPharmaDive

Agency head Scott Gottlieb's planned actions could make it easier for generic drugmakers to bring copycat medicines to market sooner.

Original Article: FDA targets regulatory 'gaming' in effort to boost generic competition

NEXT ARTICLE

More From BioPortfolio on "FDA targets regulatory 'gaming' in effort to boost generic competition"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...